|
Diabetes Medication Article
BYETTA - New Class of Diabetic Drug
Byetta is a drug derived from the saliva of the Gila monster lizard. I do know one person who is taking Byetta and has better control of her blood sugar levels. The medication has even decreased her appetite. That is a benefit for her since she is overweight.
Byetta (exenatide) is the first among a new class of diabetes drugs for Type 2 Diabetes called incretin mimetics -- synthetic medications that mimic action of a hormone that spurs insulin production after a person eats and blood sugar levels rise above a certain threshold.
Traditional diabetes drugs that promote insulin production do so even if glucose levels aren't high enough, which could cause hypoglycemia (dangerously low blood sugar).
Byetta, derived from the lizard's saliva, mimics that action of the human hormone GLP-1, which prompts the body to secrete insulin and is also thought to play a role in deciding when a person feels full. This is great because it almost acts like an appetite suppressant. Common side effects of the drug were nausea and decreased appetite.
Byetta is very unique and supposedly works in a different way than pills or insulin. By helping your body produce the right amount of insulin at the right time, Byetta helps take the guesswork out of type 2 diabetes.
Byetta is used in combination with Metformin (Glucophage) and Sulfonylurea like Amaryl® (glimepiride), Glucotrol® (glipizide), Micronase® (glyburide), and others.
Byetta is an injectable medication and comes in prefilled insulin pens where you just add a small needle and inject yourself.
The price tag is not small, but with the New Medicare Prescription Plan D, you can check out your prescription plan to see if this medication is covered.
If you are on oral diabetic medications and you are not controlled, this may be an option for you. Ask your doctor. It doesn't hurt to ask.
Please remember that primary physicians don't know everything. That is not saying they are not great doctors. No one person can know everything. Just like us nurses, some specialize in heart disease or diabetes or wound care, etc. That also applies to doctors.
If you have heart problems, you should probably get a referral to a cardiologist. The same thing with Diabetes. You may want to get a referral to an endocrinologist. Check with your primary doctor and see if a referral to an endocrinologist is right for you.
You can get more information about Byetta at http://www.byetta.com
F. Kuhn, RN
specializing in Diabetes
Diabetes Testing Center
Heart News Center
Hot Home Gym Reviews
The Secret Wisdom You Have Inside
Get Rid of Your Belly fat
Diabetes Pharmacy News
Diabetes Pharmacy
IMPORTANT: Bing News RSS feed has moved!
Diabetes is an American problem and unfortunately ... Paula, this problem, yours and America's, won't be solved with a prescription from the pharmacy. But it can be solved with changes in the way you -- all of us -- cook, and eat. Read the studies ...
Read morePaula Deen Should Turn Lemons Into Lemonade
The American Diabetes Association and SIUE are allying in a battle against diabetes this Saturday. According to pharmacy professor Jessica Kerr, this year’s program will include guest speakers and free testing. Kerr said this is the sixth year that ...
Read moreFighting diabetes with education
Bydureon is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes in multiple clinical settings. It will be available in pharmacies nationwide in February.
Read moreFDA approves first once-weekly treatment for type 2 diabetes
We found three major coffee compounds can reverse this toxic process and may explain why coffee drinking is associated with a lower risk of type 2 diabetes," says researcher Kun Huang, PhD, a professor of biological pharmacy at the Huazhong ...
Read moreWhy coffee may reduce diabetes risk
At a forum sponsored by Health Affairs, Helena Foulkes , executive vice present and chief health care strategy and marketing officer, presented findings from a new CVS Caremark study that reviewed how Pharmacy Advisor™, through targeted ...
Read moreCVS Caremark Executive Outlines Integrated Pharmacy-Based Program At Health Affairs Forum on Diabetes
The drug, a glucagon-like peptide-1 (GLP-1) receptor agonist, is approved for use alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. The company says it will be available in pharmacies throughout the US in February.
Read moreAmylin's Once-Weekly Diabetes Injection Finally Wins FDA Approval
UnitedHealth has launched similar pharmacy partnerships in 14 states to combat the growing and costly problem of diabetes. If current trends continue, within the next decade prediabetes and type 2 diabetes will affect more than half of all ...
Read moreSupermarkets' pharmacists partner with patients to combat diabetes
the most common form of diabetes, Amylin and its partner Alkermes Inc., which developed the extended-release technology for Bydureon, said in a press release Friday. The companies said the drug will be available in U.S. pharmacies in February.
Read moreFDA Approves Amylin's Bydureon Diabetes Drug
“Bydureon is now the first and only weekly diabetes therapy approved in the United States,” Amylin Chief Executive Officer Daniel Bradbury said today on a conference call. The drug will be available in pharmacies next month, he sai
Read more